Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients
Camillo Porta(University of Pavia), Alberto Riccardi(Istituti di Ricovero e Cura a Carattere Scientifico), Matteo Zimatore, Remigio Moratti(Policlinico San Matteo Fondazione), Andrea Sartore‐Bianchi(University of Milan), Chiara Paglino, Ilaria Imarisio(University of Pavia), Elisa Biscaldi(Policlinico San Matteo Fondazione), Mara De Amici(University of Pavia), Marco Danova(Azienda Socio Sanitaria Territoriale di Pavia), Lucia Bonomi
Cited by 6
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821